Abbott Laboratories (ABT)

Abbott Laboratories (ABT $124.81)
- $124.81 P/E (TTM): 15.71X Cap: $217.02B
- View ABT Profile
- View Questions on ABT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Gilead Sciences Inc. (GILD $125.67)
- $125.67 P/E (TTM): 19.22X Cap: $155.91B
- View GILD Profile
- View Questions on GILD
Abbott Laboratories (ABT $124.81)
- $124.81 P/E (TTM): 15.71X Cap: $217.02B
- View ABT Profile
- View Questions on ABT
Merck & Company Inc. (MRK $106.45)
- $106.45 P/E (TTM): 13.88X Cap: $264.21B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.03)
- $25.03 P/E (TTM): 14.66X Cap: $142.31B
- View PFE Profile
- View Questions on PFE

Q: Would you recommend starting a new position now in these big pharma stocks with rotation out of the tech sector lately? All three have decent PE, PEG and PS ratios and have been fared well in last few bear markets overall. What would your recommended allocation be across the three stocks for an investment of time line of 5 years?
Thanks!

Read Answer Asked by Scott on December 17, 2025

Amgen Inc. (AMGN $333.96)
- $333.96 P/E (TTM): 25.6X Cap: $179.83B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $125.67)
- $125.67 P/E (TTM): 19.22X Cap: $155.91B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $229.89)
- $229.89 P/E (TTM): 173.98X Cap: $406.30B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $124.81)
- $124.81 P/E (TTM): 15.71X Cap: $217.02B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $274.86)
- $274.86 P/E (TTM): 12.22X Cap: $73.42B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $207.78)
- $207.78 P/E (TTM): 19.86X Cap: $500.60B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $97.27)
- $97.27 P/E (TTM): 26.34X Cap: $124.70B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $23.19)
- $23.19 P/E (TTM): 27.0X Cap: $1.65B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Abbott Laboratories (ABT $124.81)
- $124.81 P/E (TTM): 15.71X Cap: $217.02B
- View ABT Profile
- View Questions on ABT

Q: I own ABT, and it’s down 8% today. Would it be a good idea to add to it? Thank you,

Read Answer Asked by Gervais on July 18, 2025